MYLAN has launched its generic
Lipitor, Atorvastatin Calcium tablets,
10mg, 20mg, 40mg and 80mg in
France, Belgium, the UK, the
Netherlands and Ireland following
the recipt of authorisation from each
country's respective health authority.
“Mylan's launch of Atorvastatin
Calcium Tablets will help to provide
health care systems in these
markets with an estimated US$700
million (€500 million) of savings in
2012 associated with the generic
availability of this important medicine,”
said Mylan CEO Heather Bresch.
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 14 May 12
Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.
To sign up for a free subscription, click on the button at right.
